Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Antibacterial activity against Fusobacterium nucleatum ATCC 10953 assessed as inhibition of bacterial growth incubated for 48 hrs by microbroth dilution method
Assay data:2 Tested
SummaryPubMed Citation
Antibacterial activity against Fusobacterium nucleatum by CLSI agar dilution method
Assay data:12 Tested
Antibacterial activity against Fusobacterium nucleatum
Assay data:5 Tested
Antibacterial activity against Fusobacterium nucleatum ATCC 25586
Assay data:4 Tested
Antibacterial activity against Fusobacterium nucleatum ATCC 10953
Antibacterial activity against Fusobacterium nucleatum ATCC 25586 assessed as growth inhibition at 1 to 10 uM measured after 24 hrs by WST-1 assay
Assay data:1 Tested
Antibacterial activity against Fusobacterium nucleatum ATCC 25586 assessed as growth inhibition at 100 uM measured after 24 hrs by WST-1 assay relative to control
Inhibition of Fusobacterium nucleatum ATCC 25586 recombinant MGL R373K mutant expressed in Escherichia coli BL21 (DE3) assessed as decrease in signal intensity by measuring recovery ratio by 19F NMR based competition assay relative to wild type
Assay data:28 Active, 37 Tested
SummaryCompounds, ActivePubMed Citation
Inhibition of Fusobacterium nucleatum ATCC 25586 recombinant MGL R373A mutant expressed in Escherichia coli BL21 (DE3) assessed as decrease in signal intensity by measuring recovery ratio by 19F NMR based competition assay relative to wild type
Assay data:8 Active, 37 Tested
Inhibition of Fusobacterium nucleatum ATCC 25586 recombinant MGL K238A mutant expressed in Escherichia coli BL21 (DE3) assessed as decrease in signal intensity by measuring recovery ratio by 19F NMR based competition assay relative to wild type
Assay data:20 Active, 37 Tested
Inhibition of Fusobacterium nucleatum ATCC 25586 recombinant MGL C113S mutant expressed in Escherichia coli BL21 (DE3) assessed as decrease in signal intensity by measuring recovery ratio by 19F NMR based competition assay relative to wild type
Assay data:17 Active, 37 Tested
Inhibition of Fusobacterium nucleatum ATCC 25586 recombinant MGL Y111F mutant expressed in Escherichia coli BL21 (DE3) assessed as decrease in signal intensity by measuring recovery ratio by 19F NMR based competition assay relative to wild type
Assay data:15 Active, 37 Tested
Inhibition of Fusobacterium nucleatum ATCC 25586 recombinant MGL R58K mutant expressed in Escherichia coli BL21 (DE3) assessed as decrease in signal intensity by measuring recovery ratio by 19F NMR based competition assay relative to wild type
Assay data:1 Active, 37 Tested
Inhibition of Fusobacterium nucleatum ATCC 25586 recombinant MGL R58A mutant expressed in Escherichia coli BL21 (DE3) assessed as decrease in signal intensity by measuring recovery ratio by 19F NMR based competition assay relative to wild type
Inhibition of Fusobacterium nucleatum ATCC 25586 recombinant MGL Y56F mutant expressed in Escherichia coli BL21 (DE3) assessed as decrease in signal intensity by measuring recovery ratio by 19F NMR based competition assay relative to wild type
Assay data:2 Active, 37 Tested
Inhibition of Fusobacterium nucleatum ATCC 25586 recombinant wild type MGL expressed in Escherichia coli BL21 (DE3) assessed as formation of 2-ketobutyrate using L-methionine as substrate by enzymatic assay
Assay data:37 Tested
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of Fusobacterium nucleatum ATCC 25586 recombinant wild type MGL expressed in Escherichia coli BL21 (DE3) assessed as decrease in signal intensity by 19F NMR based competition assay relative to control
Antibacterial activity against gut Fusobacterium nucleatum HM-992 assessed as reduction in bacterial growth measured after 48 hrs by CLSI based broth microdilution method
Assay data:7 Tested
Binding affinity to Fusobacterium nucleatum class I aptamer assessed as binding constant at 1H-8 resonance by (1)H relaxation dispersion NMR spectroscopy
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed Citation
Antimicrobial activity against Fusobacterium nucleatum ATCC 25586 by broth dilution assay
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on